Rite Aid Corporation (NYSE:RAD) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: September 24, 2016
Having a price of $8.12, Rite Aid Corporation (NYSE:RAD) traded -0.37% lower on the day. With the last close up 4.92% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Rite Aid Corporation has recorded a 50-day average of $7.71 and a two hundred day average of $7.71. Volume of trade was down over the average, with 5,640,605 shares of RAD changing hands under the typical 15,870,500
Zacks Investment Research has upgraded Rite Aid Corporation (NYSE:RAD) to Hold in a statement released on 9/23/2016.
With a total market value of $0, Rite Aid Corporation has 52 week low of $5.88 and a 52 week high of $8.74 with a P/E ratio of 59.93 .
In addition to Zacks Investment Research reporting its stock price target, a total of 9 brokers have issued a research note on the company. The average stock price target is $9.00 with 1 broker rating the stock a strong buy, 5 brokers rating the stock a buy, 5 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.
General Information About Rite Aid Corporation (NYSE:RAD)
Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.